Back to 
Barclays plc
Barclays plc
QNCX
1 quarters
Position history for Barclays plc's holdings in QUINCE THERAPEUTICS INC
Yes. Barclays holds 27 shares of QNCX (Quince Therapeutics), worth $491, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$491
Current Shares
27
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of QNCX: Balyasny Asset Management L.P., Millennium Management LLC, Jane Street Group, LLC, Vanguard Capital Management LLC, UBS Group AG